These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24895896)

  • 61. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.
    Medvedev AE; Ramsay RR; Ivanov AS; Veselovsky AV; Shvedov VI; Tikhonova OV; Barradas AP; Davidson CK; Moskvitina TA; Fedotova OA; Axenova LN
    Neurobiology (Bp); 1999; 7(2):151-8. PubMed ID: 10591049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
    Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
    Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO.
    Coelho Cerqueira E; Netz PA; Diniz C; Petry do Canto V; Follmer C
    Bioorg Med Chem; 2011 Dec; 19(24):7416-24. PubMed ID: 22071524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives.
    Reniers J; Meinguet C; Moineaux L; Masereel B; Vincent SP; Frederick R; Wouters J
    Eur J Med Chem; 2011 Dec; 46(12):6104-11. PubMed ID: 22018876
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
    J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
    He X; Chen YY; Shi JB; Tang WJ; Pan ZX; Dong ZQ; Song BA; Li J; Liu XH
    Bioorg Med Chem; 2014 Jul; 22(14):3732-8. PubMed ID: 24856304
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity.
    Tao G; Irie Y; Li DJ; Keung WM
    Bioorg Med Chem; 2005 Aug; 13(15):4777-88. PubMed ID: 15936201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
    J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interactions of monoamine oxidase with substrates and inhibitors.
    Dostert PL; Strolin Benedetti M; Tipton KF
    Med Res Rev; 1989; 9(1):45-89. PubMed ID: 2644497
    [No Abstract]   [Full Text] [Related]  

  • 71. Difference spectra for inhibitor binding to monoamine oxidases.
    Sablin SO; Ramsay RR
    Biochem Soc Trans; 1995 Aug; 23(3):457S. PubMed ID: 8566349
    [No Abstract]   [Full Text] [Related]  

  • 72. [Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors].
    BERNHEIMER H; BIRKMAYER W; HORNYKIEWICZ O
    Wien Klin Wochenschr; 1962 Aug; 74():558-9. PubMed ID: 13868185
    [No Abstract]   [Full Text] [Related]  

  • 73. Diphenylene Iodonium as a Prominent Halogen Bond Donor: The Case of Human Monoamine Oxidase B.
    Piña MLN; Bauzá A
    Chemphyschem; 2024 Aug; 25(15):e202400161. PubMed ID: 38687202
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An improved approach to steady-state analysis of monoamine oxidases.
    Ramsay RR; Olivieri A; Holt A
    J Neural Transm (Vienna); 2011 Jul; 118(7):1003-19. PubMed ID: 21643793
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Labware additives identified to be selective monoamine oxidase-B inhibitors.
    Stewart J; Drexler DM; Leet JE; McNaney CA; Herbst JJ
    J Biomol Screen; 2014 Dec; 19(10):1409-14. PubMed ID: 25296658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Editorial: Computational Chemistry and Synthetic Strategy of the Design of Novel Monoamine Oxidase Inhibitors.
    Mathew B
    Comb Chem High Throughput Screen; 2017; 20(6):460. PubMed ID: 29115196
    [No Abstract]   [Full Text] [Related]  

  • 77. The use of mechanism-based inactivators to probe the mechanism of monoamine oxidase.
    Silverman RB
    Biochem Soc Trans; 1991 Feb; 19(1):201-6. PubMed ID: 2037149
    [No Abstract]   [Full Text] [Related]  

  • 78. Mechanism-based enzyme inactivators.
    Silverman RB
    Methods Enzymol; 1995; 249():240-83. PubMed ID: 7791614
    [No Abstract]   [Full Text] [Related]  

  • 79. Glial cells on the radar.
    Sheridan C
    Nat Biotechnol; 2009 Feb; 27(2):114-6. PubMed ID: 19204681
    [No Abstract]   [Full Text] [Related]  

  • 80. Monoamine oxidase A and B: a useful concept?
    Mantle TJ; Tipton KF
    Biochem Pharmacol; 1978 Jan; 27(1):97-101. PubMed ID: 619909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.